期刊文献+

蛋白对HCV/HBV DNA疫苗的免疫增强作用 被引量:1

Immunogenicity of Combined HCV/HBV Immunization by DNA Prime-Protein Boost Strategy
下载PDF
导出
摘要 目的探讨蛋白对HCV/HBV DNA疫苗的免疫增强作用。方法将构建的HCV/HBV真核表达载体pcDNA-PCXS和蛋白分别免疫BALB/c小鼠,用ELISA的方法检测抗-HBs和抗-HCV Ab;3H-TdR掺入法检测免疫小鼠T淋巴细胞增殖;51Cr释放法检测免疫小鼠特异性CTLs杀伤作用。结果DNA-蛋白组抗-HBs和抗-HCV抗体均较DNA组出现早,且抗体水平明显高,DNA-蛋白组的CTL应答水平也明显高于DNA组。结论蛋白能提高DNA疫苗的特异性体液和细胞免疫功能,为DNA疫苗的实际应用提供了一种新的策略。 Objective To explore the effect of hepatitis C virus(HCV)/hepatitis B virus(HBV) bivalent vaccine by a primeboost strategy. Methods Immunize BALB/c mice with the constructed eukaryotic expression vectors PeDNA-PCXS,pcDNA-PCSS + S/ PCX protein and pcDNA3, 0 respectively. Determine anti-HBs and anti-HCV antibodies by ELISA,T lymphocyte proliferation by ^3HTdR incorporation and specific killing activity of CTLs by ^51Cr release assay. Results Compared with those immunized with pcDNAPCXS,high anti-HBs and anti-HCV titers were induced early in mice immunized with pcDNA-PCXS + S/PCX protein. The specific CTL response level induced by pcDNA-PCXS + S/PCX protein was significantly higher than that induced by pcDNA-PCXS. Conclusion DNA prime-protein boost immunization enhanced the humoral and cellular immunological functions of immunized mice. It provided a novel strategy for the practical application of DNA vaccine.
出处 《中国生物制品学杂志》 CAS CSCD 2006年第1期49-51,共3页 Chinese Journal of Biologicals
基金 云南省科委省院省校合作基金资助(200YF01)
关键词 乙型肝炎病毒 丙型肝炎病毒 DNA-蛋白免疫 免疫反应 Hepatitis B virus Hepatitis C virus DNA prime-boost immunization Immune response
  • 相关文献

参考文献8

  • 1Michel ML,Loirut D.DNA vaccines for prophylactic or therapeutic immunization against hepatitis B.Intervirology,2001,44(2-3):78-87.
  • 2Billaut-Mulot O,Idziorek T,Ban E,et al.Interleukin-18 modulates immune responses induced by HIV-1 Nef DNA prime/protein boost vaccine.Vaccine,2001,19(1):95-102.
  • 3Konishi E,Terazawa A,Imoto J.Simultaneous immunization with DNA and protein vaccines against Japanese encephalitis or dengue synergistically increases their own abilities to induce neutralizing antibody in mice.Vaccine,2003,21 (17-18):1826-1832.
  • 4Wang QM,Sun SH,Hu ZL,et al.Improved immunogenicity of a tuberculosis DNA vaccine encoding ESAT6 by DNA priming and protein boosting.Vaccine,2004,22(27-28):3622-3627.
  • 5Cho JH,Lee SW,Sung YC.Enhanced cellular immunity to hepatitis C virus nonstructural proteins by codelivery of granulocyte macrophage-colony stimulating factor gene in intramuscular DNA immunization.Vaccine,1999,17(9-10):1136-1144.
  • 6Hanke T,Schneider J,Gilbert SC,et al.DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum:immunogenicity in mice.Vaccine,1999,16(4):426-435.
  • 7Moriya O,Matsui M,Osorio M,et al.Indution of hepatitis C virusspecific cytotoxic T lymphocytes in mice by immunization with dendritic cells treated with ananthrax toxin fusion protein.Vaccine,2000,20(5-6):789-796.
  • 8Song KM,Lee SW,Sun YS,et al.Enhancement of immunoglobulin g2a and cytotoxic T-lymphocyte responses by a booster immunization with recombinant hepatitis C virus E2 protein in E2 DNA-primed mice.Virology,2000,74(6):2920-2925.

同被引文献32

  • 1周明行.恩替卡韦:一种新型治疗乙型肝炎药物的全球临床试验回顾[J].中华内科杂志,2005,44(8):635-636. 被引量:3
  • 2聂青和,张亚飞,谢玉梅,邵彬,李军,苟艳子,周永兴.实验性肝纤维化大鼠肝脏中TIMP-2基因及蛋白表达阻断研究[J].世界华人消化杂志,2005,13(23):2742-2747. 被引量:3
  • 3朱明芬,李刚.抗乙型肝炎病毒药物阿德福韦酯的耐药性研究进展[J].国外医学(内科学分册),2006,33(5):188-190. 被引量:1
  • 4Johnson MA, Jenkins JM, Bye C. A study of the pharmacokinetic interaction between lamivudine and alpha interferon[J]. Eur J Clin Pharmacol , 2000,56:289
  • 5Julio M, Orencio B, Gloria M, et al. Pilot study of recombinant human granuloeyte-maerophayge colony-stimulatingfaetor in the treatment of hepatitis B [ J ]. Hepatology , 1993,18:775
  • 6Lau GK, Tsiang M, Hou J, et al. Combination theraphy with lamivudine and fameielovir for chronic hepatitis B-infected. Chinese patients: a viral dynamics study [ J]. Hepatology , 2000,32:394
  • 7Alter MJ. Epidemiology and prevention of hepatitis B [ J ]. Semin Liver Dis ,2003,23:39
  • 8Janssen HL, Gerken G, Carreno V, et al. Interferon alfa for chronic hepatitis B infection: increased efficacy of prolonged treatment. The European concerted action on viral hepatitis B [ J ].Hepatology ,1999,30( 1 ) :238.
  • 9Tompkins WA. Immunomodulation and the rapeutic effects of oral use of interferon alpha: mechanism of action [ J ]. Interferon Cytokine Res , 1999,19 ( 8 ) :817.
  • 10Bartholomew MW,Jansen RW,Jeffers LJ, et al. Hepatitis B virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation[ J]. Lacent, 1997,349 ( 1 ) :20

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部